John Tsanakas
Overview
Explore the profile of John Tsanakas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fouzas S, Kogias C, Gioulvanidou M, Bertzouanis A, Chrysochoou E, Anthracopoulos M, et al.
Pediatr Pulmonol
. 2023 Aug;
58(11):3147-3155.
PMID: 37555768
Background: The utility of the forced oscillations technique (FOT) in cystic fibrosis (CF) remains uncertain. The aim of this study was to explore the ability of lower-frequency FOT indices, alone...
2.
Karantaglis N, Kirvassilis F, Hatziagorou E, Gkantaras A, Kontouli K, Tsanakas J, et al.
Children (Basel)
. 2023 May;
10(5).
PMID: 37238350
Bronchial provocation tests, such as the mannitol challenge, can be performed to identify and quantify the severity of bronchial hyperresponsiveness in asthmatic patients. Studies of the mannitol challenge as a...
3.
Giannakoulakos S, Gioulvanidou M, Kouidi E, Peftoulidou P, Kyrvasili S, Savvidou P, et al.
Children (Basel)
. 2022 Nov;
9(11).
PMID: 36360393
Background: Physical activity (PA) improves exercise capacity, slows the decline in lung function, and enhances Quality of Life (QoL) in patients with cystic fibrosis (pwCF). Objectives: The study aimed to...
4.
Dimitriadis V, Alexopoulou C, Amfilochiou A, Steiropoulos P, Trakada G, Siopi D, et al.
BMC Med Inform Decis Mak
. 2022 Oct;
22(1):257.
PMID: 36182922
Background: Chronic respiratory conditions are a prominent public health issue and thus, building a patient registry might facilitate both policy decision making and improvement of clinical management processes. Hellenic Registry...
5.
Hatziagorou E, Avramidou V, Gioulvanidou M, Talimtzi P, Kouroukli E, Mantsiou C, et al.
Pediatr Pulmonol
. 2022 Sep;
57(12):3069-3076.
PMID: 36059241
Background: Pulmonary exacerbations (PEx), pathogens colonizing the respiratory tract, and patients' age are associated with progressive worsening of lung function among patients with cystic fibrosis (CF). However, the effect of...
6.
Hatziagorou E, Manika K, Kyrvasili S, Kotoulas S, Chrysochoou E, Kouroukli E, et al.
Pediatr Pulmonol
. 2022 Aug;
57(12):3017-3026.
PMID: 35997065
Background: Adherence to pulmonary medication is pivotal in delaying the progression of lung disease in cystic fibrosis (CF). Further exploring the consequences of poor adherence and its impact on disease...
7.
Anifanti M, Giannakoulakos S, Hatziagorou E, Kampouras A, Tsanakas J, Deligiannis A, et al.
Sensors (Basel)
. 2022 Jul;
22(13).
PMID: 35808375
Several studies have shown that patients with cystic fibrosis (CF), even at a young age, have pulmonary and cardiac abnormalities. The main complications are cardiac right ventricular (RV) systolic and/or...
8.
Manika K, Hatziagorou E, Kotoulas S, Kyrvasili S, Sourla E, Kouroukli E, et al.
Pediatr Pulmonol
. 2022 Jan;
57(4):956-964.
PMID: 35040288
Background: This study examined the drug-specific and overall adherence of teenagers and adults with cystic fibrosis (CF) to inhaled therapies, to assess the degree of adherence, stability over a period...
9.
Hatziagorou E, Toulia I, Avramidou V, Kampouras A, Tsara V, Tsanakas J
Pediatr Pulmonol
. 2021 Jul;
56(9):3065-3067.
PMID: 34265187
Introduction: The coronavirus 2019 (COVID-19) pandemic has demanded care changes for patients with chronic disease. Patients with cystic fibrosis (CF) are considered at higher risk of developing severe manifestations in...
10.
Kampouras A, Hatziagorou E, Kalantzis T, Avramidou V, Kontouli K, Kirvassilis F, et al.
Children (Basel)
. 2021 Jul;
8(6).
PMID: 34205505
Background: The role of cardiopulmonary exercise testing (CPET) in the assessment of prognosis in CF (cystic fibrosis) is crucial. However, as the overall survival of the disease becomes better, the...